C. Adams, K. Totpal, D. Lawrence, S. Marsters, R. Pitti et al., Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5, Cell Death Differ, vol.15, issue.5, pp.751-61, 2008.

A. Ashkenazi and V. M. Dixit, Death receptors: signaling and modulation, Science, vol.281, issue.5381, pp.1305-1313, 1998.

J. Beyrath, N. Chekkat, C. R. Smulski, C. M. Lombardo, M. C. Lechner et al., Synthetic ligands of death receptor 5 display a cellselective agonistic effect at different oligomerization levels, Oncotarget, vol.7, issue.40, pp.64942-64956, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02185410

S. S. Cha, B. J. Sung, Y. A. Kim, Y. L. Song, H. J. Kim et al., Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity, J. Biol. Chem, vol.275, issue.40, pp.31171-31178, 2000.

F. A. Fellouse, B. Li, D. M. Compaan, A. A. Peden, S. G. Hymowitz et al., Molecular recognition by a binary code, J. Mol. Biol, vol.348, issue.5, pp.1153-62, 2005.

J. D. Graves, J. J. Kordich, T. H. Huang, J. Piasecki, T. L. Bush et al., Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activity, Cancer Cell, vol.26, issue.2, pp.177-89, 2014.

S. G. Hymowitz, H. W. Christinger, G. Fuh, M. Ultsch, M. O'connell et al., Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5, Mol. Cell, vol.4, issue.4, pp.563-71, 1999.

B. Li, S. J. Russell, D. M. Compaan, K. Totpal, S. A. Marsters et al., Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antiobody agonists, J. Mol. Biol, vol.361, issue.3, pp.522-558, 2006.

M. Macfarlane, M. Ahmad, S. M. Srinivasula, T. Fernandes-alnemri, G. M. Cohen et al., , 1997.

, Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL, J. Biol. Chem, vol.272, issue.41, pp.25417-25437

D. Mérino, N. Lalaoui, A. Morizot, E. Solary, and O. Micheau, TRAIL in cancer therapy: present and future challenges, Expert Opin Ther Targets, vol.11, issue.10, pp.1299-1333, 2007.

J. Mongkolsapaya, J. M. Grimes, N. Chen, X. N. Xu, D. I. Stuart et al., Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation, Nat. Struct. Biol, vol.6, issue.11, pp.1048-53, 1999.

I. Nem?ovi?ová, C. A. Benedict, and D. M. Zajonc, Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions, PloS Pathog, vol.9, issue.3, p.1003224, 2013.

T. Newsom-davis, S. Prieske, and H. Walczak, Is TRAIL the holy grail of cancer therapy, Apoptosis, vol.14, issue.4, pp.607-630, 2009.

V. Pavet, J. Beyrath, C. Pardin, A. Morizot, M. C. Lechner et al., Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity, Cancer Res, vol.70, issue.3, pp.1101-1111, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00451170

K. Pulka-ziach, V. Pavet, N. Chekkat, K. Estieu-gionnet, R. Rohac et al., Thioether analogues of disulfide-bridged cyclic peptides targeting death receptor 5: conformational analysis, dimerisation and consequences for receptor activation, Chembiochem, vol.16, issue.2, pp.293-301, 2015.

M. Sattler, J. Schleucher, and C. Griesinger, Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients, Prog. NMR Spectr, vol.34, pp.93-158, 1999.

S. P. Skinner, R. H. Fogh, W. Boucher, T. J. Ragan, L. G. Mureddu et al., CcpNmr Analysis assign: a flexible platform for integrated NMR analysis, J. Biomol. NMR, vol.66, pp.111-124, 2016.

K. Takeda, J. Stagg, H. Yagita, K. Okumura, and M. J. Smyth, Targeting death-inducing receptors in cancer therapy, Oncogene, vol.26, issue.25, pp.3745-57, 2007.

T. Tamada, D. Shinmi, M. Ikeda, Y. Yonezawa, S. Kataoka et al., , 2015.

. Trail-r2-superoligomerization, Human Monoclobal Agonistic Antibody KMTR2. Sci Rep, vol.5, p.17936

Y. S. Bax and A. , TALOS-N : Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks, J. Biomol. NMR, vol.56, pp.227-241, 2013.

H. Walczak, M. A. Degli-esposti, R. S. Johnson, P. J. Smolak, J. Y. Waugh et al., TRAIL-R2: a novel apoptosismediating receptor for TRAIL, EMBO J, vol.16, issue.17, pp.5386-5393, 1997.

Y. Wang and O. Jardetzky, Probability-based protein secondary structure identification using combined NMR chemical-shift data, Protein Sci, vol.11, issue.4, pp.852-61, 2002.

D. S. Wishart, C. G. Bigam, J. Yao, F. Abildgaard, H. J. Dyson et al.,

, 13C and 15N chemical shift referencing in biomolecular NMR, 1H, vol.6, pp.135-175